(Q38520759)

English

The influence of glycosylation on secretion, stability, and immunogenicity of recombinant HBV pre-S antigen synthesized in Saccharomyces cerevisiae

scientific article published on April 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

The influence of glycosylation on secretion, stability, and immunogenicity of recombinant HBV pre-S antigen synthesized in Saccharomyces cerevisiae (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1 reference

based on heuristic

inferred from title

Saccharomyces cerevisiae

1 reference

based on heuristic

inferred from title

author name string

Jeewon Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Jin-Seung Park

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Je-Young Moon

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Ki-Yong Kim

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Hong-Mo Moon

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

language of work or name

0 references

publication date

1 April 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

Biochemical and Biophysical Research Communications

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

303

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

427-432

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900351-6

7 January 2021

Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900351-6

7 January 2021

Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900351-6

7 January 2021

Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900351-6

7 January 2021

T-cell and antibody response characterisation of a new recombinant pre-S1, pre-S2 and SHBs antigen-containing hepatitis B vaccine; demonstration of superior anti-SHBs antibody induction in responder mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900351-6

7 January 2021

A novel, recombinant triple antigen hepatitis B vaccine (Hepacare).

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900351-6

7 January 2021

Foreign gene expression in yeast: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900351-6

7 January 2021

Enhanced secretion of human granulocyte colony-stimulating factor directed by a novel hybrid fusion peptide from recombinant Saccharomyces cerevisiae at high cell concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900351-6

7 January 2021

Novel secretion system of recombinant Saccharomyces cerevisiae using an N-terminus residue of human IL-1 beta as secretion enhancer

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900351-6

7 January 2021

A novel leader peptide which allows efficient secretion of a fragment of human interleukin 1 beta in Saccharomyces cerevisiae.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900351-6

7 January 2021

Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900351-6

7 January 2021

Enhanced immunogenicity of a human immunodeficiency virus type 1 env DNA vaccine by manipulating N-glycosylation signals. Effects of elimination of the V3 N306 glycan

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900351-6

7 January 2021

Effect of N-linked glycosylation on secretion, activity, and stability of alpha-amylase from Aspergillus oryzae

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900351-6

7 January 2021

Structural studies of alpha-N-acetylgalactosaminidase: effect of glycosylation on the level of expression, secretion efficiency, and enzyme activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900351-6

7 January 2021

Glycosylation of active human renin is necessary for secretion: effect of targeted modifications of Asn-5 and Asn-75.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900351-6

7 January 2021

Characteristics of glycosylated streptokinase secreted from Pichia pastoris: enhanced resistance of SK to proteolysis by glycosylation.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900351-6

7 January 2021

Cutting Edge: Granzyme B Proteolysis of a Neuronal Glutamate Receptor Generates an Autoantigen and Is Modulated by Glycosylation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900351-6

7 January 2021

The pre-S region of hepadnavirus envelope proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900351-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective potential of hepatitis B virus antigens other than the S gene protein

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900351-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-291X(03)00351-6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38520759&oldid=1790028866"